(Q77755098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

title

A comparison of multiple doses of fluticasone propionate and beclomethasone dipropionate in subjects with persistent asthma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference

fluticasone propionate

1 reference

beclomethasone dipropionate

inferred from title

1 reference

G D Raphael

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

R Q Lanier

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

J Baker

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

L Edwards

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

K Rickard

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

W R Lincourt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

publication date

1 May 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

The Journal of Allergy and Clinical Immunology

8 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

volume

103

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

issue

5 Pt 1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

page(s)

796-803

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

Airways remodeling is a distinctive feature of asthma and is related to severity of disease

8 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Effects of treatment on airway inflammation and thickening of basement membrane reticular collagen in asthma. A quantitative light and electron microscopic study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Effects of reducing or discontinuing inhaled budesonide in patients with mild asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Effect of Early vs Late Intervention With Inhaled Corticosteroids in Asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

A comparison of fluticasone propionate 200 micrograms/day with beclomethasone dipropionate 400 micrograms/day in adult asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

A dose-ranging study of fluticasone propionate in adult patients with moderate asthma. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Evaluation of fluticasone propionate (500 micrograms day-1) administered either as dry powder via a Diskhaler inhaler or pressurized inhaler and compared with beclomethasone dipropionate (1000 micrograms day-1) administered by pressurized inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparison of the efficacy and safety of inhaled fluticasone propionate 200 micrograms/day with inhaled beclomethasone dipropionate 400 micrograms/day in mild and moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Safety and efficacy of fluticasone and beclomethasone in moderate to severe asthma. Belgian Multicenter Study Group.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

A bioassay for topical and systemic effect of three inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Therapeutic controversies in the treatment of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Clinical experience with fluticasone propionate in asthma: a meta-analysis of efficacy and systemic activity compared with budesonide and beclomethasone dipropionate at half the microgram dose or less

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Fluticasone propionate 1 mg daily and beclomethasone dipropionate 2 mg daily: a comparison over 1 yr.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Fluticasone propionate does not influence bone metabolism in contrast to beclomethasone dipropionate

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparison of fluticasone propionate and beclomethasone dipropionate on direct and indirect measurements of bronchial hyperresponsiveness in patients with stable asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Development of fluticasone propionate and comparison with other inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

How should inhaled glucocorticoids be compared?

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparative clinical study of inhaled beclomethasone dipropionate and triamcinolone acetonide in persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Pharmacokinetics and pharmacodynamics of inhaled corticosteroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

A comparison of the systemic bioactivity of inhaled budesonide and fluticasone propionate in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparison of fluticasone propionate with beclomethasone dipropionate in moderate to severe asthma treated for one year. International Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

High-dose inhaled steroids in asthmatics: moderate efficacy gain and suppression of the hypothalamic-pituitary-adrenal (HPA) axis. Research Council of the Norwegian Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Adrenal suppression with chronic dosing of fluticasone propionate compared with budesonide in adult asthmatic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Dose-response effect for adrenal suppression with repeated twice daily inhaled fluticasone propionate and triamcinolone acetonide in adult asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Adrenal suppression with high doses of inhaled fluticasone propionate and triamcinolone acetonide in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Fluticasone propionate aerosol for the treatment of adults with mild to moderate asthma. The Fluticasone Propionate Asthma Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Effectiveness of fluticasone propionate in patients with moderate asthma: a dose-ranging study

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparative efficacy and safety of twice daily fluticasone propionate powder versus placebo in the treatment of moderate asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Efficacy of inhaled fluticasone propionate in asthma results from topical and not from systemic activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Fluticasone propionate reduces oral prednisone use while it improves asthma control and quality of life

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids

1 reference

https://api.crossref.org/works/10.1016%2FS0091-6749%2899%2970422-7

7 January 2021

10.1016/S0091-6749(99)70422-7

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10329812%20AND%20SRC:MED&resulttype=core&format=json

8 December 2019

1 reference